-
1
-
-
4644221457
-
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
-
Go, A. S., G. M. Chertow, D. Fan, C. E. McCulloch, and C. Y. Hsu. 2004. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N. Engl. J. Med. 351: 1296-1305.
-
(2004)
N. Engl. J. Med.
, vol.351
, pp. 1296-1305
-
-
Go, A.S.1
Chertow, G.M.2
Fan, D.3
McCulloch, C.E.4
Hsu, C.Y.5
-
2
-
-
3042762893
-
Potential cardiovascular risk factors in chronic kidney disease: AGEs, total homocysteine and metabolites, and the C-reactive protein
-
DOI 10.1111/j.1523-1755.2004.00736.x
-
Busch, M., S. Franke, A. Muller, M. Wolf, J. Gerth, U. Ott, T. Niwa, and G. Stein. 2004. Potential cardiovascular risk factors in chronic kidney disease: AGEs, total homocysteine and metabolites, and the C-reactive protein. Kidney Int. 66: 338-347. (Pubitemid 38870111)
-
(2004)
Kidney International
, vol.66
, Issue.1
, pp. 338-347
-
-
Busch, M.1
Franke, S.2
Muller, A.3
Wolf, M.4
Gerth, J.5
Ott, U.6
Niwa, T.7
Stein, G.8
-
3
-
-
38149070113
-
Hyperlipidemia in chronic kidney disease
-
Kaysen, G. A. 2007. Hyperlipidemia in chronic kidney disease. Int. J. Artif. Organs. 30: 987-992.
-
(2007)
Int. J. Artif. Organs
, vol.30
, pp. 987-992
-
-
Kaysen, G.A.1
-
4
-
-
0028073697
-
Lipoprotein abnormalities without hyperlipidaemia in moderate renal insufficiency
-
Samuelsson, O., P. O. Attman, C. Knight-Gibson, B. Kron, R. Larsson, H. Mulec, L. Weiss, and P. Alaupovic. 1994. Lipoprotein abnormalities without hyperlipidaemia in moderate renal insufficiency. Nephrol. Dial. Transplant. 9: 1580-1585. (Pubitemid 24344773)
-
(1994)
Nephrology Dialysis Transplantation
, vol.9
, Issue.11
, pp. 1580-1585
-
-
Samuelsson, O.1
Attman, P.-O.2
Knight-Gibson, C.3
Kron, B.4
Larsson, R.5
Mulec, H.6
Weiss, L.7
Alaupovic, P.8
-
5
-
-
42549109081
-
Apolipoprotein C-III: Understanding an emerging cardiovascular risk factor
-
Ooi, E. M., P. H. Barrett, D. C. Chan, and G. F. Watts. 2008. Apolipoprotein C-III: understanding an emerging cardiovascular risk factor. Clin. Sci. (Lond.). 114: 611-624.
-
(2008)
Clin. Sci. (Lond.)
, vol.114
, pp. 611-624
-
-
Ooi, E.M.1
Barrett, P.H.2
Chan, D.C.3
Watts, G.F.4
-
6
-
-
0019802626
-
2, and VLDL-apolipoprotein B in normal and hyperlipoproteinemic subjects
-
Huff, M. W., N. H. Fidge, P. J. Nestel, T. Billington, and B. Watson. 1981. Metabolism of C-apolipoproteins: kinetics of C-II, C-III1 and C-III2, and VLDL-apolipoprotein B in normal and hyperlipoproteinemic subjects. J. Lipid Res. 22: 1235-1246. (Pubitemid 12173299)
-
(1981)
Journal of Lipid Research
, vol.22
, Issue.8
, pp. 1235-1246
-
-
Huff, M.W.1
Fidge, N.H.2
Nestel, P.J.3
-
7
-
-
73149108842
-
Expression of apolipoprotein C-III in McA-RH7777 cells enhances VLDL assembly and secretion under lipid-rich conditions
-
Sundaram, M., S. Zhong, M. B. Khalil, P. H. Links, Y. Zhao, J. Iqbal, M. M. Hussain, R. J. Parks, Y. Wang, and Z. Yao. 2010. Expression of apolipoprotein C-III in McA-RH7777 cells enhances VLDL assembly and secretion under lipid-rich conditions. J. Lipid Res. 51: 150-161.
-
(2010)
J. Lipid Res.
, vol.51
, pp. 150-161
-
-
Sundaram, M.1
Zhong, S.2
Khalil, M.B.3
Links, P.H.4
Zhao, Y.5
Iqbal, J.6
Hussain, M.M.7
Parks, R.J.8
Wang, Y.9
Yao, Z.10
-
8
-
-
5444267382
-
Increased apoC-III production is a characteristic feature of patients with hypertriglyceridemia
-
DOI 10.1016/j.atherosclerosis.2004.06.011, PII S0021915004003648
-
Cohn, J. S., M. Tremblay, R. Batal, H. Jacques, C. Rodriguez, G. Steiner, O. Mamer, and J. Davignon. 2004. Increased apoC-III production is a characteristic feature of patients with hypertriglyceridemia. Atherosclerosis. 177: 137-145. (Pubitemid 39361148)
-
(2004)
Atherosclerosis
, vol.177
, Issue.1
, pp. 137-145
-
-
Cohn, J.S.1
Tremblay, M.2
Batal, R.3
Jacques, H.4
Rodriguez, C.5
Steiner, G.6
Mamer, O.7
Davignon, J.8
-
9
-
-
38349099256
-
Dyslipidaemia and cardiorenal disease: Mechanisms, therapeutic opportunities and clinical trials
-
Chan, D. T., A. B. Irish, G. K. Dogra, and G. F. Watts. 2008. Dyslipidaemia and cardiorenal disease: mechanisms, therapeutic opportunities and clinical trials. Atherosclerosis. 196: 823-834.
-
(2008)
Atherosclerosis
, vol.196
, pp. 823-834
-
-
Chan, D.T.1
Irish, A.B.2
Dogra, G.K.3
Watts, G.F.4
-
10
-
-
70849133524
-
Chronic kidney disease delays VLDL-apoB-100 particle catabolism: Potential role of apolipoprotein C-III
-
Chan, D. T., G. K. Dogra, A. B. Irish, E. M. Ooi, P. H. Barrett, D. C. Chan, and G. F. Watts. 2009. Chronic kidney disease delays VLDL-apoB-100 particle catabolism: potential role of apolipoprotein C-III. J. Lipid Res. 50: 2524-2531.
-
(2009)
J. Lipid Res.
, vol.50
, pp. 2524-2531
-
-
Chan, D.T.1
Dogra, G.K.2
Irish, A.B.3
Ooi, E.M.4
Barrett, P.H.5
Chan, D.C.6
Watts, G.F.7
-
11
-
-
0035897696
-
Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III)
-
Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). J. Am. Med. Assoc. 2001 ; 285: 2486-2497.
-
(2001)
J. Am. Med. Assoc.
, vol.285
, pp. 2486-2497
-
-
-
12
-
-
33744780706
-
Use of Intralipid for kinetic analysis of HDL apoC-III: Evidence for a homogeneous kinetic pool of apoC-III in plasma
-
Nguyen, M. N., D. C. Chan, K. P. Dwyer, P. Bolitho, G. F. Watts, and P. H. Barrett. 2006. Use of Intralipid for kinetic analysis of HDL apoC-III: evidence for a homogeneous kinetic pool of apoC-III in plasma. J. Lipid Res. 47: 1274-1280.
-
(2006)
J. Lipid Res.
, vol.47
, pp. 1274-1280
-
-
Nguyen, M.N.1
Chan, D.C.2
Dwyer, K.P.3
Bolitho, P.4
Watts, G.F.5
Barrett, P.H.6
-
13
-
-
0023814007
-
Metabolism of apolipoprotein C-III in normolipemic human subjects
-
DOI 10.1016/0021-9150(88)90288-2
-
Malmendier, C. L., J. F. Lontie, G. A. Grutman, and C. Delcroix. 1988. Metabolism of apolipoprotein C-III in normolipemic human subjects. Atherosclerosis. 69: 51-59. (Pubitemid 18003508)
-
(1988)
Atherosclerosis
, vol.69
, Issue.1
, pp. 51-59
-
-
Malmendier, C.L.1
Lontie, J.-F.2
Grutman, G.A.3
Delcroix, C.4
-
14
-
-
0022556147
-
Metabolism of apolipoprotein C
-
Fidge, N. H., and P. J. Nestel. 1986. Metabolism of apolipoprotein C. Methods Enzymol. 129: 443-457.
-
(1986)
Methods Enzymol.
, vol.129
, pp. 443-457
-
-
Fidge, N.H.1
Nestel, P.J.2
-
15
-
-
0033027427
-
Kinetics and mechanism of exchange of apolipoprotein C-III molecules from very low density lipoprotein particles
-
DOI 10.1016/S0167-4838(99)00009-6, PII S0167483899000096
-
Boyle, K. E., M. C. Phillips, and S. Lund-Katz. 1999. Kinetics and mechanism of exchange of apolipoprotein C-III molecules from very low density lipoprotein particles. Biochim. Biophys. Acta. 1430: 302-312. (Pubitemid 29127226)
-
(1999)
Biochimica et Biophysica Acta - Protein Structure and Molecular Enzymology
, vol.1430
, Issue.2
, pp. 302-312
-
-
Boyle, K.E.1
Phillips, M.C.2
Lund-Katz, S.3
-
16
-
-
0022182181
-
Evidence for non-equilibrating pools of apolipoprotein C-III in plasma lipoproteins
-
Bukberg, P. R., N. A. Le, H. N. Ginsberg, J. C. Gibson, A. Rubinstein, and W. V. Brown. 1985. Evidence for non-equilibrating pools of apolipoprotein C-III in plasma lipoproteins. J. Lipid Res. 26: 1047-1057.
-
(1985)
J. Lipid Res.
, vol.26
, pp. 1047-1057
-
-
Bukberg, P.R.1
Le, N.A.2
Ginsberg, H.N.3
Gibson, J.C.4
Rubinstein, A.5
Brown, W.V.6
-
17
-
-
0027495159
-
Abnormal activation of lipoprotein lipase by non-equilibrating apoC-II: Further evidence for the presence of non-equilibrating pools of apolipoproteins C-II and C-III in plasma lipoproteins
-
Tornoci, L., C. A. Scheraldi, X. Li, H. Ide, I. J. Goldberg, and N. A. Le. 1993. Abnormal activation of lipoprotein lipase by non-equilibrating apoC-II: further evidence for the presence of non-equilibrating pools of apolipoproteins C-II and C-III in plasma lipoproteins. J. Lipid Res. 34: 1793-1803.
-
(1993)
J. Lipid Res.
, vol.34
, pp. 1793-1803
-
-
Tornoci, L.1
Scheraldi, C.A.2
Li, X.3
Ide, H.4
Goldberg, I.J.5
Le, N.A.6
-
18
-
-
49649124713
-
Dose-dependent effect of rosuvastatin on VLDL-apolipoprotein C-III kinetics in the metabolic syndrome
-
Ooi, E. M., G. F. Watts, D. C. Chan, M. M. Chen, P. J. Nestel, D. Sviridov, and P. H. Barrett. 2008. Dose-dependent effect of rosuvastatin on VLDL-apolipoprotein C-III kinetics in the metabolic syndrome. Diabetes Care. 31: 1656-1661.
-
(2008)
Diabetes Care
, vol.31
, pp. 1656-1661
-
-
Ooi, E.M.1
Watts, G.F.2
Chan, D.C.3
Chen, M.M.4
Nestel, P.J.5
Sviridov, D.6
Barrett, P.H.7
-
19
-
-
0035994247
-
ApoA- and apoB-containing lipoproteins and Lp(a) concentration in non-dialyzed patients with chronic renal failure
-
DOI 10.1081/JDI-120006775
-
Kimak, E., and J. Solski. 2002. ApoA- and apoB-containing lipoproteins and Lp(a) concentration in non-dialyzed patients with chronic renal failure. Ren. Fail. 24: 485-492. (Pubitemid 34913058)
-
(2002)
Renal Failure
, vol.24
, Issue.4
, pp. 485-492
-
-
Kimak, E.1
Solski, J.2
-
20
-
-
34548396842
-
Lipoprotein metabolism in chronic renal insufficiency
-
Saland, J. M., and H. N. Ginsberg. 2007. Lipoprotein metabolism in chronic renal insufficiency. Pediatr. Nephrol. 22: 1095-1112.
-
(2007)
Pediatr. Nephrol.
, vol.22
, pp. 1095-1112
-
-
Saland, J.M.1
Ginsberg, H.N.2
-
21
-
-
0029018057
-
Modulation of lipoprotein B binding to the LDL receptor by exogenous lipids and apolipoproteins CI, CII, CIII, and e
-
Clavey, V., S. Lestavel-Delattre, C. Copin, J. M. Bard, and J. C. Fruchart. 1995. Modulation of lipoprotein B binding to the LDL receptor by exogenous lipids and apolipoproteins CI, CII, CIII, and E. Arterioscler. Thromb. Vasc. Biol. 15: 963-971.
-
(1995)
Arterioscler. Thromb. Vasc. Biol.
, vol.15
, pp. 963-971
-
-
Clavey, V.1
Lestavel-Delattre, S.2
Copin, C.3
Bard, J.M.4
Fruchart, J.C.5
-
22
-
-
0025950963
-
Mechanisms of inhibition by apolipoprotein C of apolipoprotein E-dependent cellular metabolism of human triglyceride-rich lipoproteins through the low density lipoprotein receptor pathway
-
Sehayek, E., and S. Eisenberg. 1991. Mechanisms of inhibition by apolipoprotein C of apolipoprotein E-dependent cellular metabolism of human triglyceride-rich lipoproteins through the low density lipoprotein receptor pathway. J. Biol. Chem. 266: 18259-18267. (Pubitemid 21908074)
-
(1991)
Journal of Biological Chemistry
, vol.266
, Issue.27
, pp. 18259-18267
-
-
Sehayek, E.1
Eisenberg, S.2
-
23
-
-
0031450209
-
Inhibitory effects of specific apolipoprotein C-III isoforms on the binding of triglyceride-rich lipoproteins to the lipolysis-stimulated receptor
-
Mann, C. J., A. A. Troussard, F. T. Yen, N. Hannouche, J. Najib, J. C. Fruchart, V. Lotteau, P. Andre, and B. E. Bihain. 1997. Inhibitory effects of specific apolipoprotein C-III isoforms on the binding of triglyceride-rich lipoproteins to the lipolysis-stimulated receptor. J. Biol. Chem. 272: 31348-31354.
-
(1997)
J. Biol. Chem.
, vol.272
, pp. 31348-31354
-
-
Mann, C.J.1
Troussard, A.A.2
Yen, F.T.3
Hannouche, N.4
Najib, J.5
Fruchart, J.C.6
Lotteau, V.7
Andre, P.8
Bihain, B.E.9
-
24
-
-
0020045973
-
An abnormal triglyceride-rich lipoprotein containing excess sialylated apolipoprotein C-III
-
Holdsworth, G., J. Stocks, P. Dodson, and D. J. Galton. 1982. An abnormal triglyceride-rich lipoprotein containing excess sialylated apolipoprotein C-III. J. Clin. Invest. 69: 932-939.
-
(1982)
J. Clin. Invest.
, vol.69
, pp. 932-939
-
-
Holdsworth, G.1
Stocks, J.2
Dodson, P.3
Galton, D.J.4
-
25
-
-
0035128720
-
Carbamoylation of amino acids and proteins in uremia
-
Kraus, L. M., and A. P. Kraus, Jr. 2001. Carbamoylation of amino acids and proteins in uremia. Kidney Int. Suppl. 78: S102-S107.
-
(2001)
Kidney Int. Suppl.
, vol.78
-
-
Kraus, L.M.1
Kraus Jr., A.P.2
-
26
-
-
0035130251
-
Reactive carbonyl compounds related uremic toxicity ("carbonyl stress")
-
Miyata, T., S. Sugiyama, A. Saito, and K. Kurokawa. 2001. Reactive carbonyl compounds related uremic toxicity ("carbonyl stress"). Kidney Int. Suppl. 78: S25-S31. (Pubitemid 32144065)
-
(2001)
Kidney International, Supplement
, vol.59
, Issue.78
-
-
Miyata, T.1
Sugiyama, S.2
Saito, A.3
Kurokawa, K.4
-
27
-
-
77951490605
-
Apolipoprotein C-III and the metabolic basis for hypertriglyceridemia and the dense low-density lipoprotein phenotype
-
Zheng, C., C. Khoo, J. Furtado, and F. M. Sacks. 2010. Apolipoprotein C-III and the metabolic basis for hypertriglyceridemia and the dense low-density lipoprotein phenotype. Circulation. 121: 1722-1734.
-
(2010)
Circulation
, vol.121
, pp. 1722-1734
-
-
Zheng, C.1
Khoo, C.2
Furtado, J.3
Sacks, F.M.4
-
28
-
-
0017330684
-
Very low density lipoprotein. Dissociation of apolipoprotein C during lipoprotein lipase induced lipolysis
-
Glangeaud, M. C., S. Eisenberg, and T. Olivecrona. 1976. Very low density lipoprotein. Dissociation of apolipoprotein C during lipoprotein lipase induced lipolysis. Biochim. Biophys. Acta. 486: 23-35.
-
(1976)
Biochim. Biophys. Acta
, vol.486
, pp. 23-35
-
-
Glangeaud, M.C.1
Eisenberg, S.2
Olivecrona, T.3
-
29
-
-
0028881810
-
Common genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia
-
Li, W. W., M. M. Dammerman, J. D. Smith, S. Metzger, J. L. Breslow, and T. Leff. 1995. Common genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia. J. Clin. Invest. 96: 2601-2605.
-
(1995)
J. Clin. Invest.
, vol.96
, pp. 2601-2605
-
-
Li, W.W.1
Dammerman, M.M.2
Smith, J.D.3
Metzger, S.4
Breslow, J.L.5
Leff, T.6
-
30
-
-
0027967732
-
Transcriptional regulation of the apoC-III gene by insulin in diabetic mice: Correlation with changes in plasma triglyceride levels
-
Chen, M., J. L. Breslow, W. Li, and T. Leff. 1994. Transcriptional regulation of the apoC-III gene by insulin in diabetic mice: correlation with changes in plasma triglyceride levels. J. Lipid Res. 35: 1918-1924. (Pubitemid 24353064)
-
(1994)
Journal of Lipid Research
, vol.35
, Issue.11
, pp. 1918-1924
-
-
Chen, M.1
Breslow, J.L.2
Li, W.3
Leff, T.4
-
31
-
-
0035786906
-
Peroxisome proliferator-activated receptors: From genes to physiology
-
Kliewer, S. A., H. E. Xu, M. H. Lambert, and T. M. Willson. 2001. Peroxisome proliferator-activated receptors: from genes to physiology. Recent Prog. Horm. Res. 56: 239-263.
-
(2001)
Recent Prog. Horm. Res.
, vol.56
, pp. 239-263
-
-
Kliewer, S.A.1
Xu, H.E.2
Lambert, M.H.3
Willson, T.M.4
-
32
-
-
0028998129
-
Mode of action of peroxisome proliferators as hypolipidemic drugs. Suppression of apolipoprotein C-III
-
Hertz, R., J. Bishara-Shieban, and J. Bar-Tana. 1995. Mode of action of peroxisome proliferators as hypolipidemic drugs. Suppression of apolipoprotein C-III. J. Biol. Chem. 270: 13470-13475.
-
(1995)
J. Biol. Chem.
, vol.270
, pp. 13470-13475
-
-
Hertz, R.1
Bishara-Shieban, J.2
Bar-Tana, J.3
-
33
-
-
0028817459
-
Fibrates downregulate apolipoprotein C-III expression independent of induction of peroxisomal acyl coenzyme A oxidase. A potential mechanism for the hypolipidemic action of fibrates
-
Staels, B., N. Vu-Dac, V. A. Kosykh, R. Saladin, J. C. Fruchart, J. Dallongeville, and J. Auwerx. 1995. Fibrates downregulate apolipoprotein C-III expression independent of induction of peroxisomal acyl coenzyme A oxidase. A potential mechanism for the hypolipidemic action of fibrates. J. Clin. Invest. 95: 705-712.
-
(1995)
J. Clin. Invest.
, vol.95
, pp. 705-712
-
-
Staels, B.1
Vu-Dac, N.2
Kosykh, V.A.3
Saladin, R.4
Fruchart, J.C.5
Dallongeville, J.6
Auwerx, J.7
-
34
-
-
39049083945
-
Plasma Apolipoprotein C-III Transport in central obese men: Associations with very-low density lipoprotein apolipoprotein B and high-density lipoprotein apolipoprotein A-I metabolism
-
Chan, D. C., M. N. Nguyen, G. F. Watts, and P. H. Barrett. 2008. Plasma Apolipoprotein C-III Transport in central obese men: associations with very-low density lipoprotein apolipoprotein B and high-density lipoprotein apolipoprotein A-I metabolism. J. Clin. Endocrinol. Metab. 93: 557-564.
-
(2008)
J. Clin. Endocrinol. Metab.
, vol.93
, pp. 557-564
-
-
Chan, D.C.1
Nguyen, M.N.2
Watts, G.F.3
Barrett, P.H.4
-
35
-
-
34248343423
-
Characterization of apolipoprotein A-V structure and mode of plasma triacylglycerol regulation
-
Wong, K., and R. O. Ryan. 2007. Characterization of apolipoprotein A-V structure and mode of plasma triacylglycerol regulation. Curr. Opin. Lipidol. 18: 319-324.
-
(2007)
Curr. Opin. Lipidol.
, vol.18
, pp. 319-324
-
-
Wong, K.1
Ryan, R.O.2
-
36
-
-
33845572471
-
Evidence for a complex relationship between apoA-V and apoC-III in patients with severe hypertriglyceridemia
-
Schaap, F. G., M. C. Nierman, J. F. Berbee, H. Hattori, P. J. Talmud, S. F. Vaessen, P. C. Rensen, R. A. Chamuleau, J. A. Kuivenhoven, and A. K. Groen. 2006. Evidence for a complex relationship between apoA-V and apoC-III in patients with severe hypertriglyceridemia. J. Lipid Res. 47: 2333-2339.
-
(2006)
J. Lipid Res.
, vol.47
, pp. 2333-2339
-
-
Schaap, F.G.1
Nierman, M.C.2
Berbee, J.F.3
Hattori, H.4
Talmud, P.J.5
Vaessen, S.F.6
Rensen, P.C.7
Chamuleau, R.A.8
Kuivenhoven, J.A.9
Groen, A.K.10
-
37
-
-
33748507076
-
The apolipoprotein A-V genotype and plasma apolipoprotein A-V and triglyceride levels: Prospective risk of type 2 diabetes. Results from the Northwick Park Heart Study II
-
Talmud, P. J., J. A. Cooper, H. Hattori, I. P. Miller, G. J. Miller, and S. E. Humphries. 2006. The apolipoprotein A-V genotype and plasma apolipoprotein A-V and triglyceride levels: prospective risk of type 2 diabetes. Results from the Northwick Park Heart Study II. Diabetologia. 49: 2337-2340.
-
(2006)
Diabetologia
, vol.49
, pp. 2337-2340
-
-
Talmud, P.J.1
Cooper, J.A.2
Hattori, H.3
Miller, I.P.4
Miller, G.J.5
Humphries, S.E.6
-
38
-
-
3142581525
-
ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglycerides (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis
-
DOI 10.1074/jbc.M403240200
-
Schaap, F. G., P. C. Rensen, P. J. Voshol, C. Vrins, H. N. van der Vliet, R. A. Chamuleau, L. M. Havekes, A. K. Groen, and K. W. van Dijk. 2004. ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein- triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis. J. Biol. Chem. 279: 27941-27947. (Pubitemid 38900062)
-
(2004)
Journal of Biological Chemistry
, vol.279
, Issue.27
, pp. 27941-27947
-
-
Schaap, F.G.1
Rensen, P.C.N.2
Voshol, P.J.3
Vrins, C.4
Van Der, V.H.N.5
Chamuleau, R.A.F.M.6
Havekes, L.M.7
Groen, A.K.8
Van Dijk, K.W.9
-
39
-
-
77649336543
-
Apolipoprotein A-V associates with intrahepatic lipid droplets and influences triglyceride accumulation
-
Shu, X., L. Nelbach, R. O. Ryan, and T. M. Forte. 2010. Apolipoprotein A-V associates with intrahepatic lipid droplets and influences triglyceride accumulation. Biochim. Biophys. Acta. 1801: 605-608.
-
(2010)
Biochim. Biophys. Acta
, vol.1801
, pp. 605-608
-
-
Shu, X.1
Nelbach, L.2
Ryan, R.O.3
Forte, T.M.4
-
40
-
-
4043134745
-
Rate of production of plasma and Very-Low-Density Lipoprotein (VLDL) apolipoprotein C-III is strongly related to the concentration and level of production of VLDL triglyceride in male subjects with different body weights and levels of insulin sensitivity
-
DOI 10.1210/jc.2003-032056
-
Cohn, J. S., B. W. Patterson, K. D. Uffelman, J. Davignon, and G. Steiner. 2004. Rate of production of plasma and very-low-density lipoprotein (VLDL) apolipoprotein C-III is strongly related to the concentration and level of production of VLDL triglyceride in male subjects with different body weights and levels of insulin sensitivity. J. Clin. Endocrinol. Metab. 89: 3949-3955. (Pubitemid 39071498)
-
(2004)
Journal of Clinical Endocrinology and Metabolism
, vol.89
, Issue.8
, pp. 3949-3955
-
-
Cohn, J.S.1
Patterson, B.W.2
Uffelman, K.D.3
Davignon, J.4
Steiner, G.5
-
41
-
-
77949328411
-
Cardiovascular death in dialysis patients: Lessons we can learn from AURORA
-
Sniderman, A. D., A. Solhpour, A. Alam, K. Williams, and J. A. Sloand. 2010. Cardiovascular death in dialysis patients: lessons we can learn from AURORA. Clin. J. Am. Soc. Nephrol. 5: 335-340.
-
(2010)
Clin. J. Am. Soc. Nephrol.
, vol.5
, pp. 335-340
-
-
Sniderman, A.D.1
Solhpour, A.2
Alam, A.3
Williams, K.4
Sloand, J.A.5
|